|
FOF
V-A,
L.P., a Delaware limited partnership; (c) 9,486 shares held by TPG FOF
V-B,
L.P., a Delaware limited
partnership; (d) 4,500,537 shares held by TPG Partners VI, L.P., a Delaware limited partnership; (e) 17,791 shares held by TPG FOF VI SPV, L.P., a Delaware limited partnership; (f) 185,685 shares held by TPG Biotechnology Partners III, L.P., a
Delaware limited partnership; (g) 1,547,372 shares held by TPG Iceberg
Co-Invest
LLC, a Delaware limited liability company; (h) 1,716,214 shares held by TPG Quintiles Holdco II, L.P., a Delaware limited
partnership; and (i) 89,806 shares held by TPG Quintiles Holdco III, L.P., a Delaware limited partnership (together with TPG Partners V, L.P., TPG FOF
V-A,
L.P, TPG FOF
V-B,
L.P., TPG Partners VI, L.P., TPG FOF VI SPV, L.P., TPG Biotechnology Partners III, L.P., and TPG Quintiles Holdco II, L.P., the TPG Funds). In this offering, (i) TPG Partners V, L.P. will
sell 1,446,304 shares of common stock, (ii) TPG FOF
V-A,
L.P. will sell 3,784 shares of common stock, (iii) TPG FOF
V-B,
L.P. will sell 3,051 shares of common
stock, (iv) TPG Partners VI, L.P will sell 1,447,417 shares of common stock, (v) TPG FOF VI SPV, L.P. will sell 5,722 shares of common stock, (vi) TPG Biotechnology Partners III, L.P. will sell 59,718 shares of common stock,
(vii) TPG Iceberg
Co-Invest
LLC will sell 497,650 shares of common stock, (viii) TPG Quintiles Holdco II, L.P. will sell 551,951 shares of common stock and (ix) TPG Quintiles Holdco III, L.P.
will sell 28,883 shares of common stock. The general partner of each of TPG Partners V, L.P., TPG FOF
V-A,
L.P. and TPG FOF
V-B,
L.P. is TPG GenPar V, L.P., a Delaware
limited partnership, whose general partner is TPG GenPar V Advisors, LLC, a Delaware limited liability company. The general partner of TPG Partners VI, L.P. is TPG GenPar VI, L.P., a Delaware limited partnership, whose general partner is TPG GenPar
VI Advisors, LLC. The general partner of TPG Biotechnology Partners III, L.P. is TPG Biotechnology GenPar III, L.P., a Delaware limited partnership, whose general partner is TPG Biotechnology GenPar III Advisors, LLC, a Delaware limited liability
company. The sole member of each of TPG GenPar V Advisors, LLC, TPG GenPar VI Advisors, LLC and TPG Biotechnology GenPar III Advisors, LLC is TPG Holdings I, L.P., a Delaware limited partnership, whose general partner is TPG Holdings
I-A,
LLC, a Delaware limited liability company, whose sole member is TPG Group Holdings (SBS), L.P., a Delaware limited partnership, whose general partner is TPG Group Holdings (SBS) Advisors, LLC, a Delaware
limited liability company, whose sole member is TPG Group Holdings (SBS) Advisors, Inc., a Delaware corporation. The general partner of TPG FOF VI SPV, L.P. and the managing member of TPG Iceberg
Co-Invest
LLC
is TPG Advisors VI, Inc., a Delaware corporation. The general partner of TPG Quintiles Holdco II, L.P. is TPG Advisors V, Inc., a Delaware corporation. The general partner of TPG Quintiles Holdco III, L.P. is TPG Biotech Advisors, Inc., a Delaware
corporation. David Bonderman and James G. Coulter are the sole stockholders of each of TPG Advisors VI, Inc., TPG Group Holdings (SBS) Advisors, Inc., TPG Advisors V, Inc. and TPG Biotech Advisors, Inc. and may therefore be deemed to be the
beneficial owners of the shares held by the TPG Funds. Messrs. Bonderman and Coulter disclaim beneficial ownership of the shares held by the TPG Funds except to the extent of their pecuniary interest therein. The address of each of TPG Advisors VI,
Inc., TPG Group Holdings (SBS) Advisors, Inc., TPG Advisors V, Inc., TPG Biotech Advisors, Inc. and Messrs. Bonderman and Coulter is c/o TPG Global, LLC, 301 Commerce Street, Suite 3300, Fort Worth, Texas 76102.
|